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Autophagy is the basic catabolic progress involved in cell degradation of unnecessary or dysfunctional cellular components. It 
has been proven that autophagy could be utilized for cell survival under stresses. Hypoxic-preconditioning (HPC) could reduce 
apoptosis induced by ischemia and hypoxia/serum deprivation (H/SD) in bone marrow-derived mesenchymal stem cells 
(BMSCs). Previous studies have shown that both leptin signaling and autophagy activation were involved in the protection 
against apoptosis induced by various stress, including ischemia-reperfusion. However, it has never been fully understood how 
leptin was involved in the protective effects conferred by autophagy. In the present study, we demonstrated that HPC can in-
duce autophagy in BMSCs by increased LC3-II/LC3-I ratio and autophagosome formation. Interestingly, similar effects were 
also observed when BMSCs were pretreated with rapamycin. The beneficial effects offered by HPC were absent when BMSCs 
were incubated with autophagy inhibitor, 3-methyladenine (3-MA). In addition, down-regulated leptin expression by lep-
tin-shRNA also attenuated HPC-induced autophagy in BMSCs, which in turn was associated with increased apoptosis after 
exposed to sustained H/SD. Furthermore, increased AMP-activated protein kinase phosphorylation and decreased mammalian 
target of rapamycin phosphorylation that were observed in HPC-treated BMSCs can also be attenuated by down-regulation of 
leptin expression. Our data suggests that leptin has impact on HPC-induced autophagy in BMSCs which confers protection 
against apoptosis under H/SD, possibly through modulating both AMPK and mTOR pathway. 
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Although severe hypoxia can lead to cell death for certain 
cell types such as endothelial cells, repeated episodes of 
short periods’ exposure to hypoxia (hypoxic-precondition- 
ing) have shown conferring cytoprotective benefits. Re-
search done in our laboratory and others has revealed that 
hypoxic-preconditioning protects bone marrow-derived 
mesenchymal stem cells (MSCs) from apoptosis and en-
hances cell survival after implantation [1,2]. However, the 
mechanisms underlying the beneficial effects of hypoxia 
preconditioned MSCs remain unclear. 
Autophagy is the cellular process responsible for the 
degradation and removal of damaged organelles and protein 
aggregates [3]. Autophagy is critical to cell survival. The 
interruption of autophagy may initiate severe energy metab-
olism disorder and cell death [4]. Many scientists have re-
ported that activation of autophagy protects MSCs from 
apoptosis [5]. Recent cancer research demonstrates that hy-
poxia activates autophagy and promotes tumor cell survival 
[6]. We hypothesized that hypoxic-preconditioning induces 
autophagy of bone marrow-derived MSCs (BMSCs), and it 
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activates autophagy to protect MSCs from hypoxia and se-
rum deprivation. 
Recently, research data from our lab and others suggest-
ed that hypoxia induces leptin expression [7,8]. Leptin, the 
16-kD nonglycosylated polypeptide product of the ob gene, 
is synthesized mainly by white adipose [9]. The best-known 
function of leptin is to regulate appetite. Leptin acts on cells 
in hypothalamus to reduce the production of orexigenic 
neuropeptides and reciprocally enhance the secretion of 
anorectic peptides, thus controlling food intake [10]. Be-
yond its function as a satiety factor, leptin has a wide range 
of biological functions, including reproduction, immunity, 
angiogenesis, and anti-apoptotic effects. Recent reports of 
in vivo administration of leptin activating AMP-activated 
protein kinase (AMPK) phosphorylation in peripheral tis-
sues suggests that it may influence autophagy [11,12]. In 
vitro studies demonstrated that leptin stimulated autophagy 
in cultured human or mouse cell lines, a phenomenon that 
was linked to the activation of AMPK as well as the inhibi-
tion of mammalian target of rapamycin (mTOR) [13]. 
The objective of this study was to find out whether leptin 
has any contribution to increased autophagy induced by 
hypoxic-preconditioning in BMSCs. Increased autophagy 
protects stem cells from apoptosis under sustained hypox-
ia/serum deprivation (H/SD). 
1  Materials and methods 
1.1  Cell culture 
Bone marrow was harvested from the tibia and femur of 
C57/BL6 mouse (20–25 g, male) and seeded into cell cul-
ture flasks with DMEM (Gibco, USA) containing 10% FBS 
(Gibco) and 1% penicillin-streptomycin (Gibco) at 37°C in 
a humidified atmosphere containing 5% CO2. After 24 h, 
non-adherent cells were discarded, adherent cells were 
washed three times with phosphate buffered saline (PBS). 
Fresh complete medium was added. When the cells reached 
80% confluence, they were detached using 0.25% tryp-
sin-EDTA (Gibco) and subcultured at the ratio of 1:2. All 
cells used in the experiment were passage 3. 
1.2  Hypoxic preconditioning and H/SD 
For hypoxia treatment, cells were plated at 5×104 cells per 
well in 6-well plates in complete culture medium and incu-
bated under hypoxia condition (0.5% O2, 5% CO2) using 
ProOX Model C21 system (BioSpherix, USA) for 6, 12 and 
24 h, respectively. After hypoxic preconditioning, the MSCs 
were washed with PBS, and incubated under hypoxia condi-
tion (0.5% O2, 5% CO2) with serum-free medium for 48 h. 
3-methyladenine (3-MA, at 5 mmol L1 from Sigma-   
Aldrich, USA) and rapamycin (25 mmol L1 from Cell Sig-
nal Technology, USA) were added to inhibit or induce au-
tophagy, respectively, to further investigate the role that 
autophagy activation plays in protection apoptosis in MSCs. 
1.3  Infecting BMSCs with leptin targeting shRNA 
For the leptin-knockdown assay, low passage number 
mouse BMSCs were transduced with a lentiviral vector 
carrying mouse leptin shRNA (LV-LEP-RNAi, purchased 
from Shanghai SBO Medical Biotechnology Co. Ltd. 
(Shanghai, China)). 5×105 BMSCs were seeded and incu-
bated at 37°C, 5% CO2 overnight. At ~70% confluency,  
0.5 mL of filtered lentiviral supernatant (5×107 titer units) 
containing 8 mg mL1 Polybrene (Sigma, USA) was added 
(MOI=100). After 24 h, the virus-containing medium was 
replaced with fresh medium. To select infected cells, puro-
mycin (2.5 µg mL1) was added and incubated for 24 h. 
According to Leptin mRNA sequence (NM_008493), Lep-
tin targets shRNA constructs. The target oligonucleotides 
were designed at the position in gene sequence from 897 
gene site. Two cDNA template chains were designed and 
Age I, EcoR I enzyme cleavage sites were introduced at the 
terminals. The sequences of shRNA that directed against the 
mice Leptin were as follows: sense, 5′- CCGGTCTGCAG- 
GACATTCTTCAATTCAAGAGATTGAAGAATGTCCT
GCAGATTTTTTG-3′; antisense, 5′-AATTCAAAAA- 
ATCTGCAGGACATTCTTCAATCTCTTGAATTGAAG
AATGTCCTGCAGA-3′. The sequences of scrambled 
shRNA were sense, 5′-CCGGTTCTCCGAACGTGTCA- 
CGTTTCAAGAGAACGTGACACGTTCGGAGAATTTT
TG-3′; antisense, 5′-AATTCAAAAATTCTCCGAACGT-  
GTCACGTTCTCTTGAAACGTGACACGTTCGGAG-  
AA-3′. The double-stranded oligonucleotides were cloned 
into the linear vector containing enhanced green fluorescent 
protein (EGFP) gene. 
1.4  Immunofluorescence staining 
Cells were fixed with 4% paraformaldehyde for 10 min and 
washed with PBS. The cells were then incubated with 
blocking solution (DAKO, USA) for 30 min at room tem-
perature to inhibit internal factors in cells followed by an 
overnight incubation with rabbit anti-mouse LC3 (1:200) 
(Cell Signal Technology) at 4°C. The samples were then 
stained with secondary antibody (Dylight 488 abcam) for  
1 h and Hoechst 33258 staining for 15 min at room temper-
ature. Images were detected and analyzed using a Leica 
DM550B microscope (Leica Microsystems CMS GmbH, 
Germany). 
Cells were detached from the plates and fixed with 2.5% 
glutaraldehyde in 0.1 mol L1 phosphate buffer at 4°C for  
2 h. After washed with PBS, cells were post-fixed with 1% 
osmic acid at 4°C for 1.5 h. Cells were then dehydrated by a 
serial gradient ethanol and then embedded in Embed-812 
medium (Electron Microscopy Sciences, USA). Ultrathin 
sections were cut using an Ultrotome (Leica, Reichert Ul-
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tracuts, Germany) on uncoated copper grids and stained 
with 0.2% lead citrate/1% uranyl acetate. Images were rec-
orded under a transmission electron microscope (JEM1230; 
JEOL, Japan) 
1.5  Western blotting 
Equal amounts of protein (40 µg/lane) were separated by 
electrophoresis for Western blotting analysis. The proteins 
were transferred for 2.5 h at 250 mA onto PVDF mem-
branes (Bio-Rad, UK), and the membranes were blocked for 
1 h at room temperature in 5% skim milk. The membranes 
were then incubated overnight at 4°C with primary antibod-
ies. The following primary antibodies were used: phosphor-
ylated (Thr172) and total AMPK, phosphorylated (serine 
2448) and total mTOR, beclin1, light chain 3 (LC3) of mi-
crotuble-associated protein 1, cleaved caspase-3, and β-actin 
from Cell Signal Technology. The membranes were washed 
and incubated for 1 h at room temperature in blocking solu-
tion containing peroxidase-conjugated secondary antibodies. 
Then the membranes were washed again and processed for 
analysis by using a Chemiluminescence Detection Kit (Mil-
lipore, USA) as instructed by the manufacturer.  
1.6  Terminal deoxynucleotidyl transferase-mediated 
dUTP nick end-labeling (TUNEL) assay 
TUNEL assay was performed using In Situ Cell Death De-
tection Kit, TMR red (Roche Applied Science, USA) ac-
cording to manufacturer’s procedure. Briefly, treated cells 
grown on 24-well plates with cover slips in each well were 
fixed in 4% paraformaldehyde, then permeabilized using 
0.1% TritonX-100 in 0.2% sodium citrate and incubated in 
TUNEL reaction mixture for 1 h at 37°C. Cover slips were 
mounted on glass slides with Vectashield mounting medium 
with DAPI (1.5 µg mL1, Vector Laboratories, Inc., USA) 
and analyzed by fluorescence microscopy to observe DNA 
fragmentation. Quantification of TUNEL positive cells was 
performed using Image Pro. 
1.7  Statistical analysis 
Data were analyzed using SPSS 15.0 software. All values 
were presented as mean±SD. Differences among groups 
were tested by one-way analysis of variance. Two-sided 
P-values were used and P<0.05 was considered statistically 
significant.  
2  Results 
2.1  Autophagy was induced in BMSCs after hypoxic 
preconditioning 
To investigate hypoxic preconditioning-induced autophagy 
in BMSCs, we detected the levels of the type II LC3 
(LC3-II), a biochemical marker of autophagy, by Western 
blotting. Under normal condition, LC3 protein exists in the 
cytosol as type I (LC3-I). When autophagy is activated, 
LC3-I can be recruited by autophagosome membrane and 
converted to LC3-II [14]. As shown in Figure 1A, compared 
with the control group (normoxic-treated), the ratio of 
LC3-II/LC3-I was significantly increased after HPC (6–12 h) 
and autophagy promoter rapamycin (25 nmol L1) treatment 
for 6 h, although the expression of autophagic marker be-
clin1 had no significant difference among groups. Moreover, 
treatment with autophagic inhibitor 3-MA (5 mmol L1) 
attenuated the HPC-induced autophagy. We also performed 
an immunofluorescence assay to evaluate LC3, which is an 
early marker for autophagosome. As shown in Figure 1C, 
the green dots represent LC3 that was detected in the cyto-
plasm of BMSCs. Compared to the control group, the ex-
pression of LC3 increased after HPC (612 h) and being 
treated with rapamycin (25 nmol L1). This suggested that 
HPC elicited autophagosomes. However, HPC-elicited au-
tophagosomes decreased after 3-MA treatment. 
2.2  HPC-induced autophagy protected BMSCs from 
apoptosis under H/SD condition 
To investigate the association of autophagy and apoptosis, 
we treated BMSCs with autophagy promoter rapamycin or 
hypoxic preconditioned with or without autophagy inhibitor 
3-MA, and then exposed them to H/SD for 24 h. As shown 
above, the autophagic activity in BMSCs was induced sig-
nificantly in the groups that had HPC (612 h) and rapamy-
cin treatment compared to the control group. This was 
showed by higher LC3-II/LC3-I ratio (Figure 1A) and more 
autophagosome formation (Figure 1C). 3-MA suppressed 
the autophagic activity induced by HPC in BMSCs. Addi-
tionally, apoptosis analysis performed via terminal deox-
ynucleotidyl TUNEL staining indicated that enhancing 
BMSCs autophagy by rapamycin and HPC significantly 
attenuated the apoptosis ratio of BMSCs under H/SD (Fig-
ure 2B) when compared to the control group. 3-MA-treated 
BMSCs showed a higher rate of apoptosis (Figure 2B). We 
also found the expression of cleaved caspase-3 was en-
hanced by 3-MA while reduced by rapamycin and HPC 
significantly (Figure 2A). These results suggested that 
HPC-induced autophagy played a protective role in BMSCs 
apoptosis under H/SD. 
2.3  Leptin- knockdown attenuated HPC induced au-
tophagy of BMSCs 
It has been reported that HPC increased the expression of 
leptin which could induce autophagy in several cell lines 
under certain conditions. To test whether leptin was able to 
modulate autophagy in HPC-BMSCs, we used shRNA to 
down-regulate leptin expression in BMSCs, then exposed 
BMSCs to HPC for 12 h. As shown in Figure 3A, LC3-II, 
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Figure 1  Hypoxic-preconditioning induces autophagy in BMSCs. A, Western blotting analysis of BMSCs showed that hypoxic-preconditioning (for 6 and 
12 h) induced the expression of autophagic marker LC3-II which was abrogated by 3-MA and induced by Rapamycin, compared to normoxic-treated control 
group. Beclin1 expression had no significant difference. B, Quantification of LC3-II/LC3-I was performed using the immunoreactive bands with Quantity 
One®. C, Cellular LC3 which represents autophagysome detected by immunofluorescence in BMSCs showed that hypoxic-preconditioning (for 6 and 12 h) 
increased LC3 expression which was abrogated by 3-MA and induced by Rapamycin (the green dots represent LC3 and blue one represents nucleus). D, 
Quantification of the staining of LC3 particles (green dots) obtained from immunofluorescence was performed with Image Pro. Figures are representative 
images of at least three different samples, and each experiment was repeated at least thrice. Results are expressed as mean±SD. *, P<0.05 vs. Control, Hy-
poxia 24 h, Hypoxia 6 h+3-MA, Hypoxia 12 h+3-MA and Hypoxia 24 h+3-MA. 
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Figure 2  Enhanced autophagic activity attenuates apoptosis. A, Western blotting analysis of levels of cleaved form of caspase 3 in BMSCs demonstrated 
that hypoxic-preconditioning (for 6 and 12 h) and rapamycin treatment attenuates H/SD induced apoptosis. Meanwhile, 3MA abrogated the protective effect. 
B, Terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) immunofluorescence analysis of BMSCs showed that hypoxic-preconditioning 
and rapamycin treatment attenuates the apoptosis ratio of BMSCs under H/SD while 3-MA abolished the protective effect. Fluorescent microscopic images 
show the TUNEL staining (red) and nuclear staining (blue). C, Quantification of apoptosis of BMSCs using the TUNEL stained images with Image Pro 
software. Figures are representative images of at least three different samples and each experiment was repeated at least thrice. Results are expressed as 
mean±SD. *, P<0.05 vs. Control, Hypoxia 24 h, Hypoxia 6 h+3-MA, Hypoxia 12 h+3-MA and Hypoxia 24 h+3-MA. 
identified by Western blot, elevated in HPC-WT (wild type) 
and NC (negative control) groups when compared to the 
control group. However, leptin-knockdown led to a de-
crease of the LC3-II in HPC BMSCs, whereas this negative 
effect was absent when rapamycin was added (Figure 3A). 
In addition, we found that the number of autophagosomes 
observed in HPC-Leptin- knockdown-BMSCs was signifi-
cantly decreased compared with HPC-WT and NC groups. 
This decrease could be reversed by rapamycin treatment 
(Figures 3C and 4). These results suggested that leptin is a 
key factor for the enhanced autophagic activity in MSCs 
exposed to HPC. 
2.4  Leptin knockdown attenuated the protective effect 
of HPC-induced autophagy against apoptosis in H/SD- 
treated BMSCs 
We have confirmed that leptin plays an important role in 
HPC-induced autophagy in BMSCs. To further test the 
function of leptin in the protective effects of autophagy,  
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Figure 3  leptin-knockdown reduce autophagic activity induced by hypoxic-preconditioning in BMSCs. A, Western blotting analysis of autophagic marker 
LC3-II in wild type, negative control, leptin-knockdown BMSCs showed that leptin-knockdown abrogated hypoxic-preconditioning induced autophagy 
while rapamycin could reverse this phenomenon. B, Quantification of LC3-II/LC3-I was performed using the immunoreactive bands with Quantity One®. C, 
Cellular LC3 detected by immunofluorescence in wild type, negative control, leptin-knockdown BMSCs demonstrated that leptin-knockdown reduced hy-
poxic-preconditioning induced LC3 which was reversed by rapamycin (the green dots represent LC3 and blue one represents nucleus). D, Quantification of 
the staining of LC3 particles (green dots) obtained from immunofluorescence was performed with Image Pro. Figures are representative images of at least 
three different samples, and each experiment was repeated at least thrice. Results are expressed as mean±SD. *, P<0.05 vs. WT (wild type), NC (negative 
control), Lep-KD (leptin-knockdown) and Lep-KD-H12 (leptin-knockdown BMSCs treated with hypoxic-preconditioning for 12 h). 
leptin-knockdown BMSCs were hypoxic preconditioned for 
12 h with or without rapamycin, then exposed to H/SD for 
24 h. As shown in Figure 5B, the ratio of apoptosis identi-
fied by TUNEL assay demonstrated that HPC protected WT 
and NC BMSCs from apoptosis induced by H/SD. However, 
while leptin knockdown attenuated the anti-apoptotic ca-
pacity of HPC, rapamycin treatment restored the protective 
effect (Figure 5B). From Western blot analysis, we found 
that leptin knockdown also led to the increase in cleaved 
caspase-3 at 24 h of H/SD in HPC BMSCs compared to that 
of the groups that had HPC-WT, HPC-NC, and rapamycin 
treatment (Figure 5A). These results indicated that leptin   
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Figure 4  Transmission electron micrograph of BMSCs. Electron micrographs showed that leptin-knockdown decreased the double-membraned autophagic 
vacuoles (the arrows indicated) which was induced by hypoxic-preconditioning. 
might play an important role in the protective effect of 
HPC-induced autophagy. 
2.5  HPC-induced autophagy regulated by leptin was 
associated with AMPK/mTOR pathway 
Several studies have shown that AMPK/mTOR pathway 
plays a role in regulating autophagy. During the experiment, 
we also investigated whether the AMPK/mTOR pathway is 
associated with HPC-induced autophagy, which is regulated 
by leptin. The results from Western blot indicated that HPC 
did stimulate the activation of phosphorylation of AMPKα 
as well as the dephosphorylation of mTOR after 12 h. 
However, leptin knockdown abrogated the effects of HPC 
on both AMPK phosphorylation and mTOR dephosphoryla-
tion which could be reversed by autophagy promoter ra-
pamycin (Figure 6). These results suggest that AMPK/ 
mTOR pathway might play a role in the stimulating func-
tion of leptin on HPC induced MSC autophagy. 
3  Discussion 
Scientists have been studying stem cells as useful tools for 
regenerative medicine. Stem cells have the potential to pro-
tect, repair, and regenerate impaired tissues. Working with 
embryonic stem cells has many drawbacks, such as genetic 
mutations, teratomas formation, difficult ethical considera-
tions, and possibility of immune rejection [15]. To over-
come these limitations, MSCs have been studied as an al-
ternative source for cell therapy, because they are easy to 
prepare, have immunologic advantages, and involve no eth-
ical controversy [16]. However, cell transplantation applica-
tion with MSCs is hampered by early cell death, partially 
due to oxygen or nutrient deprivation; therefore how to en-
hance MSCs survival has received much attention. 
In our current study, the results showed that autophagy 
was promoted in BMSCs after hypoxic preconditioning 
(peaked at 12 h) and it served as a protector for BMSCs 
apoptosis under H/SD. Leptin may regulate HPC-induced 
autophagy via AMPK/mTOR pathway. To our knowledge 
this is the first report showing that leptin regulates 
HPC-induced autophagy in BMSCs, which protects BMSCs 
from apoptosis under H/SD. 
Autophagy plays key roles in cellular physiology, such as 
degradation of long-lived proteins, organelle turnover, ad-
aptation to nutrient depletion, and cellular homeostasis con-
sistency [17,18]. Autophagy which has contributions to cell 
survival or death in response to a stressor can be dramati-
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Figure 5  Leptin deficiency attenuates the protective effect of hypoxic-preconditioning. A, Western blotting analysis of levels of cleaved form of caspase 3 
in BMSCs demonstrated that the protective effect of hypoxic-preconditioning was attenuated by leptin-knockdown. B, Terminal deoxynucleotidyl transfer-
ase dUTP nick end labelling (TUNEL) immunofluorescence analysis of BMSCs showed that hypoxic-preconditioning attenuated the apoptosis ratio of 
BMSCs under H/SD, while leptin-knockdown abrogated the protective effect. Fluorescent microscopic images show the TUNEL staining (red) and nuclear 
staining (blue). C, Quantification of apoptosis of BMSCs using the TUNEL stained images with Image Pro software. Figures are representative images of at 
least three different samples and each experiment was repeated at least thrice. Results are expressed as mean±SD. *, P<0.05 vs. WT (wild type), NC (nega-
tive control), Lep-KD (leptin-knockdown) and Lep-KD-H12 (leptin-knockdown BMSCs treated with hypoxic-preconditioning for 12 h). 
cally induced by multiple stresses. The relationship between 
autophagy and death has been characterized in many con-
texts and has been discussed comprehensively; however, it 
has not been extensively studied in BMSCs. Hypoxia and 
serum deprivation are both energy-limiting stresses impair-
ing the function of mitochondria and stimulating the pro-
duction of radicals. According to numerous studies, adap-
tive autophagy is essential for cell survival by supplying 
energy and eliminating radicals and damaged organelles 
[1921]. The protective effect of autophagy has been pre-
viously reported in models of ischemic injury in the heart, 
brain, and under conditions of H/SD in cell culture [2224]. 
Recently, Sanchez et al. [20] reported that during long pe-
riod of serum deprivation, MSCs could utilize autophagy to 
provide needed energy and secret anti-apoptotic factors for 
survival. In our research we found that autophagic pathway 
was activated effectively by hypoxic-preconditioning as 
shown by increased autophagosomes, LC3-II, and decreased
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Figure 6  AMPK/mTOR pathway examined by Western blotting. A, Western blotting analysis showed that leptin-knockdown down-regulated the p-AMPK 
in BMSCs which was up-regulated by hypoxic-preconditioning. Meanwhile, rapamycin abrogated the negative effect of leptin deficiency. B, Leptin- knock-
down up-regulated the p-mTOR in BMSCs which was down-regulated by hypoxic-preconditioning. 
apoptosis ratio of BMSCs under H/SD. Moreover, sup-
pressing autophagy by its inhibitor 3-MA resulted in in-
creased apoptotic levels in H/SD-treated MSCs. In contrast, 
rapamycin, an autophagy inducer, could decrease the degree 
of apoptosis. These data suggested that HPC could promote 
autophagy in BMSCs as a pro-survival mechanism rather 
than a pro-death pathway in BMSCs under H/SD.  
Interestingly, research data from our lab and others sug-
gested that the expression of leptin was increased in MSCs 
after HPC. Leptin is a well-known molecule that promotes 
cell survival both in vivo and in vitro through various 
mechanisms [25,26]. In addition, recent research suggested 
that leptin induced autophagy in cultured human or mouse 
cell lines [13]. In this study conducted on BMSCs, we 
showed that leptin knockdown reduced HPC-induced au-
tophagy by decreasing the LC3-II and autophagosomes. 
Autophagy promoter rapamycin abrogated these changes 
observed in the HPC-leptin-knockdown BMSCs group, 
suggesting that leptin does regulate HPC-induced autophagy. 
Furthermore, HPC-induced, autophagy mediated anti- 
apoptosis effects on BMSCs under H/SD were significantly 
diminished by leptin-knockdown, while rapamycin reversed 
this leptin-knockdown effect. This confirmed our hypothe-
sis that HPC induces autophagy through leptin and pro-
motes BMSCs survival during H/SD. 
It is noteworthy that in our study, the level of beclin1, a 
well-known autophagy-related protein, was not associated 
with the autophagic activity. However, as previous studies 
reported, the expression of beclin1 is augmented signifi-
cantly when autophagy is induced [22,27]. This discrepancy 
may be due to the difference in cell types, stimuli, and dura-
tion of treatment applied to individual studies. Carloni et al. 
[28] have reported that applying hypoxia-ischemia stimula-
tion for the same duration only induced beclin1 in neurons 
but not in other cells. Moreover, the treatment time associ- 
ated with autophaic markers’ increase also differed widely 
from cell to cell. Thus, in our study, the short period of HPC 
may be the reason of lack of beclin1 expression. 
Up to now, many signaling pathways have been sug-
gested in autophagy regulation. AMPK is thought to be an 
important positive regulator of autophagy via its indirect 
inhibition to mTOR [29]. Recent investigations suggested 
that leptin administration activates AMPK. Therefore, we 
monitored the expression and activation levels of AMPK/ 
mTOR pathway to further study the mechanism underlying 
HPC-induced autophagy. Interestingly, we found that HPC 
increased the AMPK activation and simultaneously reduced 
the mTOR activation significantly. Moreover, leptin- 
knockdown not only counteracted the mTOR suppression 
and AMPK activation, but also eliminated the autophagy 
induced by HPC. In contrast, autophagy promoter rapamy-
cin changed the signaling pathway of leptin-knock- down 
mediated by AMPK activation and mTOR, indicating that 
leptin and rapamycin may share the same signaling pathway 
in regulating autophagy in BMSCs, i.e., through mTOR 
inhibition. There may be many other mediators responsible 
for the autophagy. As other studies reported, leptin could 
also activate PI3K/Akt, STAT3, NF-kappaB, and ERK1/2 
pathway to mediate the protection effects which are found 
to be able to signal autophagy as well [3032]. Thus, further 
study is necessary to identify other signaling pathways used 
by leptin to regulate HPC-induced autophagy and protect 
BMSCs against apoptosis. 
In conclusion, the results reported here strongly suggest 
that HPC induced autophagy in BMSCs protects BMSCs 
from apoptosis under H/SD. Leptin may be an important 
factor in regulating HPC-induced autophagy via AMPK/ 
mTOR pathway. These findings provide valuable infor-
mation for better understanding of autophagy-regulated 
mechanisms that promote BMSCs survival. 
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